Biosynex SA (FRA:0DL)

Market Cap	18.19M +3.0%
Revenue (ttm)	97.95M -5.9%
Net Income	-70.99M
EPS	-4.82
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	0.9300
Previous Close	1.2000
Day's Range	0.9300 - 0.9300
52-Week Range	0.4630 - 1.8480
Beta	n/a
RSI	61.12
Earnings Date	Apr 30, 2026

About Biosynex

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products. The company was founded in 1993 and is based in Illkirch-Graf...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1993
• Employees: 454
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0DL

Financial Performance

In 2024, Biosynex's revenue was 101.17 million, an increase of 8.81% compared to the previous year's 92.98 million. Losses were -43.33 million, 17.3% more than in 2023.